ACM Research (ACMR) Cash & Equivalents (2016 - 2026)

ACM Research has disclosed Cash & Equivalents across 11 years of filings, most recently posting $872.3 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 90.77% year-over-year to $872.3 million; the TTM figure through Mar 2026 stood at $872.3 million (up 90.77% YoY), while the FY2025 annual figure was $757.4 million, up 85.88% from the prior year.
• Cash & Equivalents improved to $872.3 million in Q1 2026, from $757.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for ACMR reached as high as $1.1 billion in Q3 2025 and fell as low as $182.1 million in Q4 2023.
• The 5-year median for Cash & Equivalents is $333.5 million (2024), against an average of $415.3 million.
• The widest YoY moves for Cash & Equivalents: up 421.22% in 2022, down 55.92% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $248.0 million in 2022, then retreated by 26.56% to $182.1 million in 2023, then jumped by 123.76% to $407.4 million in 2024, then surged by 85.88% to $757.4 million in 2025, then advanced by 15.17% to $872.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $872.3 million, $757.4 million, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.